Summary
The proinflammatory cytokine interleukin-1β (IL-1β) is produced as inactive proIL-1β and then processed by caspase-1 to become active. In 2002, it was demonstrated that the intracellular multiprotein complex known as the inflammasome functions as a molecular platform to trigger activation of caspase-1. Inflammasomes are known to function as intracellular sensors for a broad spectrum of various pathogen-associated and damage-associated molecular patterns. In 1985, it was demonstrated that Porphyromonas gingivalis, a representative bacterium causing chronic periodontitis, induces IL-1 production by murine peritoneal macrophages. Since then, many studies have suggested that IL-1, particularly IL-1β plays key roles in the pathogenesis of periodontal diseases. However, the term "inflammasome" was not used until the involvement of inflammasomes in periodontal disease was suggested in 2009. Several subsequent studies on the roles of the inflammasome in the pathogenesis of periodontal diseases have been published. Interestingly, two contradictory reports on the modulation of inflammasomes by P. gingivalis have been published. Some papers have described how P. gingivalis activates the inflammasome to produce IL-1β whereas some stated that P. gingivalis inhibits inflammasome activation to subvert immune responses. Several lines of evidence have suggested that the inflammasome activation is modulated by periodontopathic bacteria other than P. gingivalis. Hence, studies on the roles of inflammasomes in the pathogenesis of periodontal diseases began only 8 years ago and many pathological roles of inflammasomes remain to be clarified.
K E Y W O R D S
inflammasome, periodontal disease, Porphyromonas gingivalis and damage-associated molecular patterns [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] (Table 1) . We previously demonstrated that whole cells of two Mycoplasma species and Streptococcus sanguinis activate the NLRP3 inflammasome to produce IL-1β. 24, 25 Periodontitis, a chronic inflammation that occurs in many adults, is a major cause of tooth loss and is characterized by chronic infection associated with Gram-negative anaerobic bacteria in the subgingival biofilm, which leads to destruction of the tissue supporting the teeth. Subgingival biofilms containing several Gram-negative rods are strongly involved in the onset and progression of periodontitis. Among Gram-negative rods, Porphyromonas gingivalis is a representative periodontal pathogen in chronic periodontitis. 26 In this review, we focus on the historical aspects of the pathological roles of inflammasomes in periodontal diseases, and the modulation of inflammasome activation by P. gingivalis as a first step for developing a new therapeutic strategy.
| INVOLVEMENT OF IL-1 IN PERIODONTAL DIS E A S E S
The reported roles of IL-1 in the pathogenesis of periodontal diseases are summarized in Figure 2 .
In 1985, the first paper regarding the functional role of IL-1 in periodontal disease was published. 27 However, this study only demonstrated that lipopolysaccharide (LPS) from P. gingivalis induces IL-1 production by murine peritoneal macrophages, but did not directly determine the roles of IL-1 in the pathogenesis of adult periodontal disease. The first report on the role of IL-1,
Production of biologically active interleukin-1β (IL-1β). Interleukin-1β is produced as proIL-1β in the cytosol, which is biologically inactive, through activation of nuclear factor-κB by Toll-like receptor-mediated signaling. Biologically active IL-1β is produced after processing by caspase-1, which is also processed from pro-caspase-1 by activation of the intracellular sensor inflammasome. The inflammasome is an intracellular multiprotein complex comprising "nucleotide-binding domain leucine-rich repeat-containing receptor", the adaptor protein "apoptosis-associated speck-like protein containing a caspase-recruitment domain" and procaspase- 
| INVOLVEMENT OF INFL AMMA SOME S IN PERI ODONTAL D IS E A S E S
As described above, the inflammasome was first named in 2002 as a molecular platform triggering activation of caspase-1 and processing of proIL-1β and proIL-18. 2 Therefore, we next focus on studies of the roles of the inflammasome in the pathogenesis of periodontal diseases.
In 2009, 7 years after the discovery of the inflammasome, it was first demonstrated that NLRP3 and NLRP2, but not ASC, are expressed at significantly higher levels in gingival tissues of subjects with inflammatory periodontal disease than in healthy subjects, and a positive correlation was found between NLRP3 and IL-1β or IL-18 expression levels in these tissues. 38 In addition, in vitro data demon- and IL-18 gene expression at lower concentrations, followed by their downregulation at higher concentrations, which was also evident for In 2015, it was demonstrated that the intensity of NLRP3 expression was significantly higher in chronic periodontitis or generalized aggressive periodontitis than in healthy tissue, and a more significant difference was observed in the periodontal epithelium layer. 49 In addition, they showed that NLRP1 was minimally expressed in healthy and periodontitis gingival tissues, whereas AIM2 was expressed at a higher level in the chronic periodontitis group than in other subjects.
NLRP1 and AIM2 are also known to mediate inflammasome assembly against microbial infections.
9,10
In 2017, the study was carried out to compare salivary levels of NLRP3, ASC, caspase-1 and IL-1β from patients with aggressive periodontitis or chronic periodontitis and periodontally healthy controls as well as elucidate its association with periodontal clinical status. 50 The study indicates the possibility that salivary levels of NLRP3, ASC and IL-1β, but not caspase-1, act as strong/independent indicators of amount and extent of periodontal breakdown in both chronic periodontitis and aggressive periodontitis. 
| MODUL ATI ON OF THE

| Activation of inflammasomes
As described above, in 1985, P. gingivalis LPS was shown to induce IL-1 production by using murine peritoneal macrophages. 27 At that time, however, it was not known that the intracellular sensor inflammasome regulates the production of IL-1β. In addition, it was demonstrated that ASC, one component of the inflammasome complex, is involved in inducing cytokines such as IL-1β in response to P. gingivalis infection through a caspase-1-dependent pathway, 56 although the term "inflammasome" was not used. (Table 2 ).
Similar findings have been reported in another study. 58 They also demonstrated that activation of the NLRP3 inflammasome does not rely on P. gingivalis infection unless stimulated by P. gingivalis LPS and/or extracellular ATP. Hence, these findings suggest that the NLRP3 inflammasome is an important mediator of the inflammatory response in the gingival epithelium.
Several lines of evidence [59] [60] [61] support the finding that periodontitis is associated pathologically with atherosclerotic vascular disease, although the details remain unclear. It was recently found that macrophages primed with P. gingivalis LPS and then treated with cholesterol crystals released IL-1β. 62 In 2014, it was demonstrated that expression levels of inflammasome components in gingival tissues from patients with chronic periodontitis are much higher than in those from healthy controls 77 BMDM, bone-marrow-derived macrophage; GEC, gingival epithelial cells; GF, gingival fibroblasts; HMGB1, high mobility group box; ND, not described; UVEC, umbilical vein endothelial cells.
and that P. gingivalis induces the activation of NLRP3 and AIM2
inflammasome via TLR2 and TLR4 signaling, leading to IL-1β secretion and pyroptic cell death. 63 In addition, studies suggested that P. gingivalis-induced NLRP3 inflammasome activation depends on ATP release, K + efflux and cathepsin B.
In 2015, it was reported that P. gingivalis can activate the NLRP3 inflammasome, in which the pathogenic factors gingipain and fimbriae play important roles, suggesting that the NLRP3 inflammasome plays a critical role in periodontal disease and atherosclerosis induced by P. gingivalis challenge through sustained inflammation. 64 In 2017, the authors of the previous study also demonstrated that oral injection of P. gingivalis to wild-type mice, but not to NLRP3-deficient mice, significantly increased alveolar bone loss and gingival gene expression of proIL-1β and proIL-18. 65 In addition, they showed that P. gingivalis upregulated production of IL-1β and IL-18 by peritoneal macrophages from wild-type mice, but not from NLRP3-deficient mice.
In 2017, Yoshida et al 74 There is growing evidence of a relationship between diabetes and inflammasome activation. 66 Recently, infection by P. gingivalis, a major bacterial species in periodontal disease, were recognized as a common complication of diabetes. It has been demonstrated that human gingival fibroblasts infected with P. gingivalis grown in brainheart infusion medium containing high glucose showed increased expression of IL-1β and NLRP3. 67 Hence, these publications suggest that activation of the inflammasome by P. gingivalis leads to IL-1β production and plays important roles in the pathogenicity of diabetes and atherosclerotic vascular disease as well as periodontal diseases.
| Inhibition of inflammasome activation
Several lines of evidence suggest that P. gingivalis inhibits inflammasome activation, leading to evasion of the host immune response (Table 3 ).
In 2012, it was reported that P. gingivalis suppresses inflammasome activation by another periodontal bacterium such as F. nucleatum, but not by ATP or nigericin. 68 Based on the finding that P. gingivalis limits both the number of cells taking up beads and the number of beads taken up for bead-positive cells, they speculated that the mechanism by which P. gingivalis inhibits inflammasome activation contributes to suppression of bacterial endocytosis.
In 2013, it was reported that 10 species from subgingival biofilms, including P. gingivalis, reduce NLRP3 and IL-1β levels but do not affect AIM2 expression in human gingival fibroblasts and that exclusion of P. gingivalis from the biofilm partially rescued NLRP3
and IL-1β expression. 69 These results suggest that subgingival biofilms downregulate NLRP3 and IL-1β expression, partly because of the existence of P. gingivalis. Therefore, these dampened host innate immune responses may favor the survival and persistence of associated biofilm species in periodontal tissues.
A recent study found that treatment of endothelial cells with live cells, but not with heat-killed cells, of P. gingivalis induced proteolysis of NLRP3, but this proteolysis was not observed after ATP pretreatment and/or P. gingivalis LPS stimulation. 70 Additionally, the levels of secreted IL-1β significantly increased after ATP pretreatment and/or P. gingivalis LPS stimulation, but not after P. gingivalis infection. These data demonstrate that P. gingivalis and its LPS differentially controlled the NLRP3 inflammasome pathway in endothelial cells, suggesting a novel potential mechanism developed by P. gingivalis to reduce IL-1β secretion and escape the host immune response.
As described above, P. gingivalis stimulates proIL-1β synthesis but not mature IL-1β secretion, unless the P2X7 receptor is activated by extracellular ATP. 57 An additional study demonstrated that fimbriae dampen P2X 7 -dependent IL-1β secretion. 71 Briefly, the authors showed that when bone-marrow-derived macrophages from wild-type or P2X 7 -deficient mice were infected with P. gingivalis 381 or the isogenic fimbria-deficient (DPG3) strain with or without subsequent ATP stimulation, DPG3 induced higher IL-1β secretion after ATP stimulation compared with 381 in wild-type bone-marrow-derived macrophages, but not in P2X 7 -deficient cells.
Recently, it was demonstrated that a nucleoside-diphosphate kinase of P. gingivalis inhibits caspase-1 activation and IL-1β secretion in gingival epithelial cells by downregulating the ATP-P2X 7 signaling pathway and reducing the release of the high mobility group box 1 protein, a proinflammatory danger signal. 77 Hence, these publications suggest that P. gingivalis inhibits inflammasome activation to subvert host immune responses.
| SUMMARY AND CON CLUS I ON S
Interleukin-1β is produced as biologically inactive proIL-1β and then processed by caspase-1, also known as IL-1β-converting enzyme, to active IL-1β. 78 In 2002, it was first demonstrated that the intracellular multiprotein complex known as the inflammasome functions as a molecular platform that triggers activation of caspase-1. 38 Since then, several studies on the roles of the inflammasome in the pathogenesis of periodontal diseases have been published.
Of these reports, there are two contradictory reports regarding the modulation of inflammasomes by P. gingivalis, a representative bacterium in chronic periodontitis. Some papers described how P. gingivalis activates the inflammasome, whereas some papers said that P. gingivalis inhibits inflammasome activation. The discrepancy between studies may be attributed to the different cell types used in the studies or to differences between a live single-type bacterial infection and biofilm infection. In addition, many pathogenic bacteria such as Yersinia spp., 80 Legionella pneumophila, 81 Pseudomonas aeruginosa 82 and Mycobacterium tuberculosis 83 inhibit inflammasome activation, 3, 23 although the mechanisms differ from each other.
Inflammasomes are intracellular sensors that drive host immune responses to maintain homeostasis of host cells and tissues. Hence, the activity of P. gingivalis in inhibiting inflammasome activation is more strongly associated with chronic inflammation such as adult chronic periodontitis. Inhibition of inflammasome activation by P. gingivalis may allow other bacteria in the subgingival dental plaque as well as the bacterium to survive for longer periods of time in the gingival tissue and contribute to periodontal diseases.
As described above, studies on the roles of inflammasomes in the pathogenesis of periodontal diseases began only 8 years ago. In the oral cavity, there are teeth embedded in gingival tissue, which are mainly made of phosphate and calcium, and sometimes several artificial dental prostheses to restore intraoral defects, including resins, ceramics and metals such as titanium, cobalt and chromium, which is extremely different from the nasal, stomach and gut cavities. More recently, interestingly, it was found that titanium ions also stimulate inflammasome activation. 84 Hence, many unknown pathological roles of inflammasomes in various oral diseases including periodontal diseases remain to be clarified.
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